Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido [1,2-a]pyrimidin-6-one derivatives

Details for Australian Patent Application No. 2007318927 (hide)

Owner MITSUBISHI TANABE PHARMA CORPORATION SANOFI-AVENTIS

Inventors Slowinski, Franck; Yaiche, Philippe; Lochead, Alistair; Saady, Mourad

Agent A J Park

Pub. Number AU-A-2007318927

PCT Pub. Number WO2008/056266

Priority 06291725.7 07.11.06 EP

Filing date 6 November 2007

Wipo publication date 15 May 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 33/06 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/056266 Priority application(s): WO2008/056266

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007318930-A process of liquefying a gaseous methane-rich feed for obtaining liquid natural gas

2007318926-A set of sequences for targeting expression and control of the posttranslationnal modifications of a recombinant polypeptide